Our Entrepreneurs

Luciana Guimarães

Integra Medical

Luciana Guimarães Luciana Guimarães
“I saw an opportunity to improve treatment for patients suffering from chronic diseases.”
Country
Brazil
Industry
Healthcare
Employees
120
Year selected
2011
partner
Vanessa Vazquez
Website

Company Snapshot

The treatment of chronic diseases like hypertension, schizophrenia, and Parkinson’s has been a healthcare problem without a cure — until now. Brazilian entrepreneurs Luciana and Vanessa founded Integra Medical in 2005 to offer patients suffering from chronic diseases improved treatment and ongoing support. Integra provides patients with home guidance from doctors, nurses, and psychologists who monitor their treatment and guide patients through major milestones like finishing medication or changing doses, in addition to print and digital resources. Their unique programs give patients access to a portfolio of services and support that helps maintain a high quality of treatment and reduces drop-out rates to one in five from the industry standard of one in two. Luciana and Vanessa are poised to capitalize on their first-mover advantage lucrative partnerships with many of Brazil’s largest pharmaceutical companies to fuel continued expansion in Brazil and support a new office in Portugal.

From the Entrepreneurship Blog

Events

40 High-Impact Entrepreneurs from 13 Countries Join Network at the 56th International Selection Panel in Miami; Endeavor Peru Welcomes First Entrepreneurs

December 12th, 2014 — by admin

Miami, FL – December 11, 2014 – Endeavor selected 40 high-impact entrepreneurs leading 22 companies in 13 countries at its 56th International Selection Panel. Endeavor now supports 1,030 High-Impac…

Read more

In the news

Report on Scale-Up Entrepreneurship in the U.K. Examines Research from Endeavor

December 19th, 2014 — by admin

A new report titled The Scale-Up Report on UK Economic Growth has identified the impact of scale-up companies on the country's economy and highlighted the importance of supporting high-impact, high-…

Read more

Contact us

Press center

Community

Newsletter Sign Up